• β-Elemene: Translational Insights for Neuroprotection and Me

  2026-07-20

  Explore β-Elemene’s unique mechanisms as a neuroprotective and metabolic modulator, with a focus on its role in apoptosis, inflammation, and obesity research. This article provides advanced guidance for leveraging β-Elemene in experimental workflows, grounded in the latest scientific evidence.

• LPS-Mediated Protection of Macrophages via System Xc− and AB

  2026-07-20

  This study uncovers how lipopolysaccharide (LPS) selectively protects macrophages from antitumor drug-induced cytotoxicity by upregulating the cystine/glutamate antiporter system Xc− and engaging ABCC1-mediated drug transport pathways. These mechanistic insights highlight new molecular targets for preserving immune cell viability during chemotherapy, offering a foundation for developing safer cancer treatment strategies.

• Indazole/Indole Glucagon Receptor Antagonists for T2DM Contr

  2026-07-19

  Lin et al. describe the design and evaluation of a new series of indazole- and indole-based glucagon receptor antagonists, targeting hepatic glucose production in type 2 diabetes. Their work establishes potent small molecules with strong in vitro and in vivo activity, providing a foundation for next-generation therapies and research tools.

• Super-Enhancer Hijacking of LINC01977 Drives LUAD Progressio

  2026-07-18

  Zhang et al. revealed that super-enhancer-mediated upregulation of the lncRNA LINC01977 fuels early-stage lung adenocarcinoma (LUAD) progression by activating the canonical TGF-β/SMAD3 pathway. These findings highlight a critical epigenetic mechanism underlying LUAD malignancy and identify LINC01977 and Smad3 as promising research targets for future therapeutic strategies.

• FK866 (APO866): Precision NAMPT Inhibition in Cancer Researc

  2026-07-17

  FK866 (APO866) delivers highly selective NAMPT inhibition, enabling advanced exploration of NAD metabolism and targeted cell death pathways in hematologic malignancies and beyond. This guide details rigorous protocols, troubleshooting strategies, and workflow enhancements to maximize impact in cancer biology research.

• Roscovitine (Seliciclib): Precision Tools for Cell Cycle Arr

  2026-07-17

  Roscovitine (Seliciclib, CYC202) stands out for its selective inhibition of CDKs, enabling robust, reversible cell cycle arrest and precise tumor biology modeling. This guide delivers actionable workflows, troubleshooting strategies, and insights that empower advanced cancer research with unmatched reproducibility and mechanistic clarity.

• Technical Guidance: Calpain Inhibitor I, ALLN in Apoptosis &

  2026-07-16

  Calpain Inhibitor I, ALLN is a high-purity, selective tool for inhibiting calpain- and cathepsin-mediated proteolysis in apoptosis assays and ischemia-reperfusion injury models. It is intended solely for research workflows and is not suitable for diagnostic or therapeutic applications.

• Sulfo-Cy5 Carboxylic Acid: Fluorescent Dye for Life Sciences

  2026-07-16

  Sulfo-Cy5 carboxylic acid stands out as a hydrophilic, high-sensitivity fluorescent dye for life sciences, enabling robust protein and peptide labeling in aqueous systems. Its superior solubility and minimized fluorescence quenching empower researchers to achieve reliable imaging and quantitation in advanced immunological and neuroscience applications.

• SARS-CoV-2 PLpro Modulates ER Protein Stability via Deubiqui

  2026-07-15

  This study elucidates how the SARS-CoV-2 papain-like protease (PLpro), an ER-anchored viral enzyme, disrupts host protein homeostasis by deubiquitinating and selectively cleaving key ER-associated regulatory proteins. The results expand the understanding of viral manipulation of the ubiquitin-proteasome system and have broad implications for antiviral research and proteostasis studies.

• Vorinostat in Oncology: Applied Workflows and Troubleshootin

  2026-07-15

  Vorinostat (suberoylanilide hydroxamic acid) empowers researchers to precisely modulate epigenetic states and induce apoptosis across diverse cancer biology workflows. This guide translates cutting-edge HDAC inhibitor research into actionable protocols, troubleshooting strategies, and comparative insights for reproducible results.

• WIP1/PPM1D Inhibition Amplifies Renal Pyroptosis via p38 MAP

  2026-07-14

  The referenced study reveals that WIP1 (PPM1D) acts as a suppressor of renal tubular pyroptosis in sepsis-associated acute kidney injury by downregulating p38 MAPK signaling. Pharmacological inhibition of PPM1D with CCT007093 increases pyroptotic markers in both cell and animal models, providing mechanistic insight into inflammation-driven kidney injury and highlighting new experimental strategies for dissecting p38 MAPK-mediated cell fate.

• Social Memory Maintenance via Neuroligin 1 Proteolysis in Mi

  2026-07-14

  Liu et al. reveal that maintenance of social memory in mice depends on social interaction-induced proteolytic processing of neuroligin 1 (NLG1) in the ventral hippocampus. Their findings link α- and γ-secretase-mediated NLG1 cleavage and the resulting NLG1-CTD fragment to synaptic plasticity and memory, offering a mechanistic bridge between extracellular cues and intracellular signaling in social cognition.

• Luminescent ATP Detection Assay Kit: Unveiling Mitochondrial

  2026-07-13

  Explore how the Luminescent ATP Detection Assay Kit empowers precise cellular ATP quantification and unlocks new insights into mitochondrial apoptosis. This article provides advanced guidance for researchers investigating energy metabolism and cell death mechanisms.

• Rottlerin: Selective PKC Inhibitor for Precision Cell Assays

  2026-07-13

  Rottlerin stands out as a selective PKC inhibitor, enabling robust, reproducible assays in cancer, virology, and endothelial biology. Explore advanced workflows, practical troubleshooting, and evidence-based protocol enhancements that maximize the scientific value of APExBIO’s Rottlerin in translational research.

• Mapping GCGR Allosteric Binding Sites Using Dynamic Structur

  2026-07-12

  This study leverages both crystallographic and computational approaches to map the inferential binding sites of small-molecule glucagon receptor antagonists, with a focus on MK 0893. The findings clarify binding pocket diversity and stability, informing rational drug design for type 2 diabetes research.

15668 records 1/1045 page Next 12345 下5页 Last page